/ SuspendedNot Applicable Bioequivalence study of empagliflozin+ Linagliptin 25+ 5 mg of Darou Darman Pars company in comparison with the reference sample of Glyxambi made by Boehringer company.
/ CompletedNot Applicable Bioequivalence study of empagliflozin 25 mg of Daro Darman Pars company in comparison with the reference sample of Jardiance made by Boehringer company.
/ CompletedNot Applicable Bioequivalence study of empagliflozin 12.5 combined tablet with metformin 1000 mg of Daro Darman Pars company in comparison with the reference sample of Syngardi made by Boehringer company.
100 Clinical Results associated with Darou Darman Pars Co.
0 Patents (Medical) associated with Darou Darman Pars Co.
100 Deals associated with Darou Darman Pars Co.
100 Translational Medicine associated with Darou Darman Pars Co.